Potassium Iodide Delayed-Release Tablets
» Potassium Iodide Delayed-Release Tablets contain not less than 94.0 percent and not more than 106.0 percent of the labeled amount of KI for Tablets of 300 mg or more, and not less than 92.5 percent and not more than 107.5 percent for Tablets of less than 300 mg.
Packaging and storage— Preserve in tight containers.
Disintegration 701— Proceed as directed for Delayed-Release (enteric coated) Tablets: the Tablets do not disintegrate after 1 hour of agitation in simulated gastric fluid TS, but they disintegrate within 90 minutes in simulated intestinal fluid TS.
Other requirements— Tablets respond to the Identification test and meet the requirements for Uniformity of dosage units and Assay under Potassium Iodide Tablets.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Behnam Davani, Ph.D., M.B.A.
Senior Scientist
1-301-816-8394		 (MDAA05) Monograph Development-Antivirals and Antimicrobials
701 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106		 (BPC05) Biopharmaceutics05
USP32–NF27 Page 3350
Pharmacopeial Forum: Volume No. 34(6) Page 1481